SKI Market

A+| A| A-|

Indian Indices

Sensex

77,100.47 109.25
( 0.14%)

Global Indices

Nasdaq

51,823.54 -118.08
(-0.23%)

Dow Jones

7,358.68 -19.81
(-0.27%)

Hang Seng

69,065.93 -3,300.41
(-4.56%)

Nikkei 225

10,515.14 -14.75
(-0.14%)

Forex

USD-INR

94.55 -0.19
(-0.20%)

EUR-INR

107.36 -0.64
(-0.59%)

GBP-INR

124.56 -0.65
(-0.52%)

JPY-INR

0.58 0.00
(-0.30%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

ERIS Lifesciences Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

540596

INE406M01024

230.6075957

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ERIS

79.59

20214.19

EPS(TTM)

Face Value()

Div & Yield %

18.33

0.49

Back

damodar industries ltd

Tanla Platforms consolidated net profit rises 10.85% in the December 2025 quarter

Jan 27,2026

Net profit of Tanla Platforms rose 10.85% to Rs 131.37 crore in the quarter ended December 2025 as against Rs 118.51 crore during the previous quarter ended December 2024. Sales rose 12.06% to Rs 1121.04 crore in the quarter ended December 2025 as against Rs 1000.43 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1121.04	1000.43	12
OPM %	17.00	16.33	-
PBDT	197.32	171.34	15
PBT	164.82	146.77	12
NP	131.37	118.51	11

77,100.47 109.25 ( 0.14%)

51,823.54 -118.08 (-0.23%)

7,358.68 -19.81 (-0.27%)

69,065.93 -3,300.41 (-4.56%)

10,515.14 -14.75 (-0.14%)

94.55 -0.19 (-0.20%)

107.36 -0.64 (-0.59%)

124.56 -0.65 (-0.52%)

0.58 0.00 (-0.30%)